RecruitingPhase 2NCT06087874
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Studying Microtia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chinese University of Hong Kong
- Principal Investigator
- Chi C Wang, ProfessorChinese University of Hong Kong
- Intervention
- Vivomixx®(dietary_supplement)
- Enrollment
- 94 target
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2024 – 2025
Study locations (1)
- Prince of Wales Hospital, Hong Kong, New Territories, Hong Kong
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06087874 on ClinicalTrials.govOther trials for Microtia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT06289283Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in BladderTheodor Bilharz Research Institute
- RECRUITINGPHASE2NCT05288790Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCTVanderbilt University Medical Center